6 research outputs found
9120 Second-line amrubicin vs topotecan in extensive-disease small cell lung cancer (ED-SCLC) sensitive to first-line platinum-based chemotherapy: updated results of a randomized phase 2 trial
Full text linkClinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC)
Full text linkFurther characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpura
No full textAntitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors
No full text
